INSIGHTS ON CLINICAL TRIAL DESIGN
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
Why Early RTSM Involvement Matters
Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.
-
Human Abuse Potential: Subjective Ratings
Accurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.
-
The True Science Behind eCOA, Shaped By Patient And Site Insights
This webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.
-
Together, We Are On A Mission: Enabling Treatments To Reach Patients4/22/2026
This AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.
-
Clinical Trial Budgeting Faces Pressure To Modernize6/26/2026
Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
The Triple Effect Of Community-Based Clinical Trials6/24/2026
Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.
-
How Community-Based Research Models Expand Access9/9/2025
As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?
-
Disclosure Management System: Build Or Buy?6/19/2025
Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.
With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.
-
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
-
Optimize clinical trial protocols by aligning scientific goals with real-world site operations. Improve enrollment, reduce site burden, and minimize costly amendments through data-driven design.
-
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.